Skip to main content
OpenTrials

Clinical trial condition

Monoclonal Gammopathy of Undetermined Significance

Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.

82 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Monoclonal Gammopathy of Undetermined Significance trial results

Recruiting

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

NCT06140524

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Health Ann Arbor, Michigan, United States
  • NYU Langone Health Perlmutter Cancer Center New York, United States
View all 39 locations
View Trial Details
Recruiting

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

NCT02269592

Conditions
B-cell Malignancy, Low-grade, Blood Protein Disorders, Bone Marrow Diseases, +36 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Dana Farber Cancer Institute at St. Elizabeth's Brighton, Massachusetts, United States
  • Dana Farber Cancer Institute at Merrimack Valley Methuen, Massachusetts, United States
  • Dana Farber Cancer Institute at Milford Regional Medical Center Milford, Massachusetts, United States
View Trial Details
Recruiting

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

NCT07214324

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations
  • Istituto Ortopedico Rizzoli IRCCS Bologna, Italy
  • UO Ematologia Azienda Ospedaliero-Universitaria "Policlinico Rodolico San Marco" Catania, Italy
  • UOC di Ematologia, Dipartimento di Oncologia, AOU Policlinico "Paolo Giaccone" Palermo, Italy
  • S.C Ematologia - Azienda USL IRCCS di Reggio Emilia Reggio Emilia, Italy
View Trial Details
Recruiting

Promoting Diagnosis and Management of AL in Italy (ProDigALIty)

NCT06383143

Conditions
AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +17 more
Locations
  • Azienda Ospedaliera Policlinico Consorziale Bari, Italy
  • Azienda Ospedaliero Universitaria Policlinico G.Rodolico - San Marco Catania, Italy
  • Fondazione Irccs Policlinico San Matteo Pavia, Italy
  • EMATOLOGIA - Città della Scienza e Salute - Torino Torino, Italy
View Trial Details
Recruiting

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

NCT05640843

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Emory University (Data Collection Only) Atlanta, Georgia, United States
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
View Trial Details

Related conditions